Full Disclosure Policy Affecting CE Activities
As a sponsor accredited by the Accreditation Council for Pharmacy Education (ACPE), it is the policy of the University of Tennessee College of Pharmacy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Program Director and Participating Faculty reported the following:
Camille Thornton, PharmD, BCPS
Clinical Pharmacist, HIV-AIDS
University of Tennessee
• Dr Thornton reports receiving honoraria from Abbott Laboratories, Bristol-Meyers Squibb Company, Gilead Sciences, LLC, GlaxoSmithKline, and Pfizer, Inc.
John J. Faragon, PharmD
Clinical Pharmacist-HIV Medicine
Albany Medical Center
Albany, New York
• Dr Faragon reports receiving honoraria from Abbott Laboratories and Gilead Sciences, LLC; and being a former employee for Abbott Laboratories.
Christopher W. James, PharmD
Clinical Pharmacy Specialist
HIV Community Program
Christiana Care Health Services
• Dr James reports having no financial or advisory relationships with corporate organizations related to this activity.
Christopher Miller, PharmD, BCPS
Assistant Professor, Pharmacy Practice
Albany College of Pharmacy
Clinical Pharmacist — AMC Division of HIV Medicine
Albany, New York
• Dr Miller reports serving as a consultant for Gilead Sciences, LLC; and receiving honoraria from Gilead Sciences, LLC.
Notice: In accordance with the ACPE Criteria for Quality, the audience is advised that articles in this continuing pharmaceutical education contain no reference(s) to unlabeled or unapproved uses of drugs or devices.
University of Tennessee Advanced Studies in Pharmacy provides disclosure information from contributing authors, lead presenters, and participating faculty. University of Tennessee Advanced Studies in Pharmacy does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.